SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062207
Filing Date
2019-11-12
Accepted
2019-11-12 09:21:48
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17632_110q.htm 10-Q 1585404
2 EX-31.1 a19-17632_1ex31d1.htm EX-31.1 10487
3 EX-31.2 a19-17632_1ex31d2.htm EX-31.2 10471
4 EX-32.1 a19-17632_1ex32d1.htm EX-32.1 7065
5 EX-32.2 a19-17632_1ex32d2.htm EX-32.2 7031
  Complete submission text file 0001104659-19-062207.txt   7575355

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT repl-20190930.xml EX-101.INS 1757961
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20190930.xsd EX-101.SCH 57578
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20190930_cal.xml EX-101.CAL 70827
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20190930_def.xml EX-101.DEF 177532
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT repl-20190930_lab.xml EX-101.LAB 530338
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20190930_pre.xml EX-101.PRE 397487
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 191206571
SIC: 2836 Biological Products, (No Diagnostic Substances)